Abbott Laboratories (ABT) is acquiring Cardiovascular Systems (CSII) in a deal expected to be completed soon, pending final closing conditions.
Published first on TheFly
See Insiders’ Hot Stocks on TipRanks >>
Read More on CTKB:
- Cytek® Biosciences Introduces New 20-Color AML Panel
- Cytek Biosciences price target lowered to $15 from $18 at Piper Sandler
- Cytek Biosciences reports Q4 revenue $48.3M, consensus $50.22M
- Cytek Biosciences Reports Fourth Quarter and Full Year 2022 Financial Results
- DiaSorin completes sale of Flow Cytometry & Imaging business to Cytek
